Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cahill

Showing results (341-350 of 425) with videos related to

Pageof 43
Sort By:
Neuro-Oncology Advances|December 8, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma WorkshopMarta Penas-Prado, Jing Wu, Daniel P Cahill, et al.
Plos One|August 4, 2009
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission areaMark E Polhemus, Shon A Remich, Bernhards R Ogutu, et al.
Neurosurgery|July 28, 2020
Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter StudyAlexander T Yahanda, Bhuvic Patel, Amar S Shah, et al.
World Neurosurgery|January 6, 2020
A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I GliomasAlexander T Yahanda, Bhuvic Patel, Garnette Sutherland, et al.
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade GliomaJo Sasame, Naoki Ikegaya, Masahito Kawazu, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 22, 2019
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent <i>AKT1 E17K</i> Mutations in Foramen Magnum MeningiomasSally R Williams, Tareq A Juratli, Brandyn A Castro, et al.
Acta Neuropathologica|October 22, 2015
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histologyGanesh M Shankar, Nina Lelic, Corey M Gill, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Cell Stem Cell|December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug ToleranceBrian B Liau, Cem Sievers, Laura K Donohue, et al.
Pageof 43

Showing results (341-350 of 425) with videos related to

Sort By:
Pageof 43
Neuro-Oncology Advances|December 8, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma WorkshopMarta Penas-Prado, Jing Wu, Daniel P Cahill, et al.
Plos One|August 4, 2009
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission areaMark E Polhemus, Shon A Remich, Bernhards R Ogutu, et al.
Neurosurgery|July 28, 2020
Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter StudyAlexander T Yahanda, Bhuvic Patel, Amar S Shah, et al.
World Neurosurgery|January 6, 2020
A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I GliomasAlexander T Yahanda, Bhuvic Patel, Garnette Sutherland, et al.
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade GliomaJo Sasame, Naoki Ikegaya, Masahito Kawazu, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 22, 2019
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent <i>AKT1 E17K</i> Mutations in Foramen Magnum MeningiomasSally R Williams, Tareq A Juratli, Brandyn A Castro, et al.
Acta Neuropathologica|October 22, 2015
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histologyGanesh M Shankar, Nina Lelic, Corey M Gill, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Cell Stem Cell|December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug ToleranceBrian B Liau, Cem Sievers, Laura K Donohue, et al.
Pageof 43